首頁 > 市場調查報告書 > 製藥

循環系統

市場調查報告書

商品編碼

2049616

Telmisartan市場報告：按適應症、分銷管道和地區分類（2026-2034 年）

Telmisartan Market Report by Indication (Hypertension, Cardiovascular Risk Reduction), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2026-2034

出版日期: 2026年05月01日 | 出版商:

IMARC | 英文 147 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2025年全球Telmisartan市場規模達39億美元。展望未來，IMARC Group預測，到2034年，該市場規模將達到49億美元，2026年至2034年的複合年成長率為2.49%。

Telmisartan是一種非胜肽類血管收縮素受體阻斷劑（ARB），用於治療高血壓和心血管疾病。它通常以片劑或口服油性懸浮液的形式提供，並與其他藥物聯合使用以增強療效。此藥透過抑制體內醛固酮的生成發揮降血壓作用，進而減少鈉和水的吸收，最終降低血壓。Telmisartan還能放鬆血管並促進腎功能。然而，它可能引起多種副作用，包括頭暈、頭暈、咳嗽和鼻竇疼痛。

Telmisartan市場趨勢：

全球製藥業的顯著成長是推動市場前景光明的一大關鍵因素。此外，高血壓、糖尿病和各種腎臟疾病的日益普遍也促進了市場成長。Telmisartan已被證實能有效改善胰島素敏感性，並調節葡萄糖和脂質代謝，從而幫助控制慢性糖尿病腎病變和其他由久坐生活方式引起的疾病。製藥公司也正在推出Telmisartan製劑的學名藥，為高血壓和心血管疾病患者提供更經濟有效的治療方案。此外，製藥公司正大力投資研發用於治療糖尿病腎臟病的新型Telmisartan製劑，也促進了市場成長。人口老化加劇和醫療基礎設施的顯著改善等其他因素預計也將進一步推動市場擴張。

本報告解答的主要問題

全球Telmisartan市場迄今的發展軌跡如何？預計未來幾年將如何發展？
新冠疫情對全球Telmisartan市場產生了哪些影響？
主要區域市場有哪些？
按適應症分類的市場組成是什麼？
按分銷管道分類的市場區隔如何？
該產業價值鏈包含哪些不同階段？
該行業的主要促進因素和挑戰是什麼？
全球熱米沙坦市場的結構如何？主要參與者有哪些？
這個行業的競爭有多激烈？

Telmisartan is a non-peptide angiotensin receptor blocker (ARB), which is used as a prescription drug for the treatment of hypertension and cardiovascular disorders. It is commonly available in tablets and oral oil suspension variants and is administered with other medications to enhance its efficacy. It exhibits antihypertensive properties and inhibits aldosterone production in the body, thereby leading to a decrease in sodium and water absorption and subsequent reduction in the blood pressure. Telmisartan also relaxes the blood vessels and promotes kidney function. However, it may cause various side effects, such as dizziness, lightheadedness, cough and sinus pain.

TELMISARTAN MARKET TRENDS:

Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, the increasing prevalence of high blood pressure, diabetes and various kidney-related disorders is providing a thrust to the market growth. Telmisartan has been proven effective in modifying genes for insulin sensitization and regulating glucose and lipid metabolism, which aids in managing chronic diabetic kidney disease and other disorders caused by sedentary lifestyles. Pharmaceutical manufacturers are also launching generic versions of telmisartan medications to provide cost-effective treatment to hypertension and cardiovascular ailments. Additionally, drug manufacturers are investing significantly in the research and development (R&D) of advanced telmisartan medications for the treatment of diabetic nephropathy, which is also contributing to the growth of the market. Other factors, including the rising geriatric population, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market further.

KEY MARKET SEGMENTATION:

Breakup by Indication:

Hypertension
Cardiovascular Risk Reduction

Breakup by Distribution Channel:

Hospital Pharmacies
Drug Stores and Retail Pharmacies
Online Stores

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

COMPETITIVE LANDSCAPE:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Aurobindo Pharma USA, Boehringer Ingelheim International GmbH, Cipla Limited, Hikma Pharmaceuticals plc, Jubilant Cadista Pharmaceutical, Sanofi S.A., Solco Healthcare (Prinston Pharmaceutical Inc.) and Torrent Pharmaceuticals Ltd.

KEY QUESTIONS ANSWERED IN THIS REPORT

How has the global telmisartan market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global telmisartan market?
What are the key regional markets?
What is the breakup of the market based on the indication?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global telmisartan market and who are the key players?
What is the degree of competition in the industry?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Telmisartan Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Indication

6.1 Hypertension
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Cardiovascular Risk Reduction
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Distribution Channel

7.1 Hospital Pharmacies
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Drug Stores and Retail Pharmacies
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Online Stores
- 7.3.1 Market Trends
- 7.3.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Aurobindo Pharma USA
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
  - 13.3.2.3 Financials
- 13.3.3 Boehringer Ingelheim International GmbH
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
- 13.3.4 Cipla Limited
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
  - 13.3.4.3 Financials
  - 13.3.4.4 SWOT Analysis
- 13.3.5 Hikma Pharmaceuticals plc
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
  - 13.3.5.4 SWOT Analysis
- 13.3.6 Jubilant Cadista Pharmaceutical
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
- 13.3.7 Sanofi S.A.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Solco Healthcare (Prinston Pharmaceutical Inc.)
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
- 13.3.9 Torrent Pharmaceuticals Ltd
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Telmisartan Market: Major Drivers and Challenges
Figure 2: Global: Telmisartan Market: Sales Value (in Billion USD), 2020-2025
Figure 3: Global: Telmisartan Market Forecast: Sales Value (in Billion USD), 2026-2034
Figure 4: Global: Telmisartan Market: Breakup by Indication (in %), 2025
Figure 5: Global: Telmisartan Market: Breakup by Distribution Channel (in %), 2025
Figure 6: Global: Telmisartan Market: Breakup by Region (in %), 2025
Figure 7: Global: Telmisartan (Hypertension) Market: Sales Value (in Million USD), 2020 & 2025
Figure 8: Global: Telmisartan (Hypertension) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 9: Global: Telmisartan (Cardiovascular Risk Reduction) Market: Sales Value (in Million USD), 2020 & 2025
Figure 10: Global: Telmisartan (Cardiovascular Risk Reduction) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 11: Global: Telmisartan (Hospital Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 12: Global: Telmisartan (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 13: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
Figure 14: Global: Telmisartan (Drug Stores and Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 15: Global: Telmisartan (Online Stores) Market: Sales Value (in Million USD), 2020 & 2025
Figure 16: Global: Telmisartan (Online Stores) Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 17: North America: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 18: North America: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 19: United States: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 20: United States: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 21: Canada: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 22: Canada: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 23: Asia-Pacific: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 24: Asia-Pacific: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 25: China: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 26: China: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 27: Japan: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 28: Japan: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 29: India: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 30: India: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 31: South Korea: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 32: South Korea: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 33: Australia: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 34: Australia: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 35: Indonesia: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 36: Indonesia: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 37: Others: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 38: Others: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 39: Europe: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 40: Europe: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 41: Germany: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 42: Germany: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 43: France: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 44: France: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 45: United Kingdom: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 46: United Kingdom: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 47: Italy: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 48: Italy: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 49: Spain: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 50: Spain: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 51: Russia: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 52: Russia: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 53: Others: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 54: Others: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 55: Latin America: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 56: Latin America: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 57: Brazil: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 58: Brazil: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 59: Mexico: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 60: Mexico: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 61: Others: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 62: Others: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 63: Middle East and Africa: Telmisartan Market: Sales Value (in Million USD), 2020 & 2025
Figure 64: Middle East and Africa: Telmisartan Market: Breakup by Country (in %), 2025
Figure 65: Middle East and Africa: Telmisartan Market Forecast: Sales Value (in Million USD), 2026-2034
Figure 66: Global: Telmisartan Industry: SWOT Analysis
Figure 67: Global: Telmisartan Industry: Value Chain Analysis
Figure 68: Global: Telmisartan Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Telmisartan Market: Key Industry Highlights, 2025 and 2034
Table 2: Global: Telmisartan Market Forecast: Breakup by Indication (in Million USD), 2026-2034
Table 3: Global: Telmisartan Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
Table 4: Global: Telmisartan Market Forecast: Breakup by Region (in Million USD), 2026-2034
Table 5: Global: Telmisartan Market: Competitive Structure
Table 6: Global: Telmisartan Market: Key Players

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

Telmisartan市場：依成分、適應症、劑型、通路和地區分類

FAQ

Telmisartan市場報告：按適應症、分銷管道和地區分類（2026-2034 年）

Telmisartan Market Report by Indication (Hypertension, Cardiovascular Risk Reduction), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), and Region 2026-2034

Telmisartan市場趨勢：

本報告解答的主要問題

目錄

第1章：序言

第2章：調查方法

第3章執行摘要

第4章：引言

第5章：全球Telmisartan市場

第6章 市場區隔：依適應症分類

第7章 市場區隔：依分銷通路分類

第8章 市場區隔：依地區分類

第9章 SWOT 分析

第10章：價值鏈分析

第11章：波特五力分析

第12章：價格分析

第13章 競爭格局